111 Capital Takes $413,000 Position in Privia Health Group, Inc. $PRVA

111 Capital purchased a new stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA) during the second quarter, Holdings Channel.com reports. The firm purchased 17,954 shares of the company’s stock, valued at approximately $413,000.

A number of other large investors have also made changes to their positions in the company. US Bancorp DE raised its holdings in shares of Privia Health Group by 2.4% during the first quarter. US Bancorp DE now owns 18,487 shares of the company’s stock valued at $415,000 after acquiring an additional 429 shares during the period. Park Avenue Securities LLC raised its holdings in shares of Privia Health Group by 3.6% during the first quarter. Park Avenue Securities LLC now owns 15,229 shares of the company’s stock valued at $342,000 after acquiring an additional 532 shares during the period. CWM LLC raised its holdings in shares of Privia Health Group by 50.3% during the first quarter. CWM LLC now owns 1,804 shares of the company’s stock valued at $40,000 after acquiring an additional 604 shares during the period. GAMMA Investing LLC raised its holdings in shares of Privia Health Group by 113.1% during the first quarter. GAMMA Investing LLC now owns 2,866 shares of the company’s stock valued at $64,000 after acquiring an additional 1,521 shares during the period. Finally, Smartleaf Asset Management LLC raised its holdings in shares of Privia Health Group by 24.5% during the first quarter. Smartleaf Asset Management LLC now owns 9,060 shares of the company’s stock valued at $205,000 after acquiring an additional 1,785 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.

Analysts Set New Price Targets

Several research firms have weighed in on PRVA. Evercore ISI dropped their price objective on shares of Privia Health Group from $30.00 to $28.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 9th. Citigroup reiterated an “outperform” rating on shares of Privia Health Group in a research note on Friday, August 29th. Piper Sandler dropped their price objective on shares of Privia Health Group from $36.00 to $35.00 and set an “overweight” rating on the stock in a research note on Monday, August 11th. Zacks Research upgraded shares of Privia Health Group from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 19th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Privia Health Group in a research note on Saturday, September 27th. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Privia Health Group currently has an average rating of “Moderate Buy” and a consensus target price of $28.58.

Privia Health Group Price Performance

Shares of Privia Health Group stock opened at $24.09 on Monday. Privia Health Group, Inc. has a fifty-two week low of $16.47 and a fifty-two week high of $26.09. The firm has a fifty day moving average price of $21.99 and a two-hundred day moving average price of $22.42. The company has a market cap of $2.96 billion, a PE ratio of 219.02, a price-to-earnings-growth ratio of 3.29 and a beta of 0.83.

Privia Health Group (NASDAQ:PRVA) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.03). Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. The company had revenue of $521.15 million during the quarter, compared to the consensus estimate of $466.97 million. During the same period last year, the company earned $0.19 earnings per share. Privia Health Group’s revenue for the quarter was up 23.4% on a year-over-year basis. Privia Health Group has set its FY 2025 guidance at EPS. Analysts expect that Privia Health Group, Inc. will post 0.14 earnings per share for the current fiscal year.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.